<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//TaxonX//DTD Taxonomic Treatment Publishing DTD v0 20100105//EN" "../../nlm/tax-treatment-NS0.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:tp="http://www.plazi.org/taxpub" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">89</journal-id>
      <journal-id journal-id-type="index">urn:lsid:arphahub.com:pub:CCBBD2E1-BDAF-5702-AE4B-0E4910A4C7D6</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">Pharmacia</journal-title>
        <abbrev-journal-title xml:lang="en">PHAR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0428-0296</issn>
      <issn pub-type="epub">2603-557X</issn>
      <publisher>
        <publisher-name>Bulgarian Pharmaceutical Scientific Society</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3897/pharmacia.71.e116917</article-id>
      <article-id pub-id-type="publisher-id">116917</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="scientific_subject">
          <subject>Pharmaceutics</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Evaluation of types and concentration of bile salts impact on physical properties of nisoldipine-loaded bilosomes</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Naji</surname>
            <given-names>Ghada Hamid</given-names>
          </name>
          <email xlink:type="simple">ghada@pharmacoj.com</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Al Gawhari</surname>
            <given-names>Fatima J.</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>
        <addr-line content-type="verbatim">Department of Pharmaceutics, College of Pharmacy, University of Babylon, Hillah, Babylon Governorate, Iraq</addr-line>
        <institution>University of Babylon</institution>
        <addr-line content-type="city">Hillah</addr-line>
        <country>Iraq</country>
      </aff>
      <aff id="A2">
        <label>2</label>
        <addr-line content-type="verbatim">Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Iraq</addr-line>
        <institution>University of Baghdad</institution>
        <addr-line content-type="city">Baghdad</addr-line>
        <country>Iraq</country>
      </aff>
      <author-notes>
        <fn fn-type="corresp">
          <p>Corresponding author: Ghada Hamid Naji (<email xlink:type="simple">ghada.hamed1100p@copharm.uobaghdad.edu.iq</email>)</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2024</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>09</day>
        <month>02</month>
        <year>2024</year>
      </pub-date>
      <volume>71</volume>
      <fpage>1</fpage>
      <lpage>7</lpage>
      <uri content-type="arpha" xlink:href="http://openbiodiv.net/5307766A-5863-5AAD-9DC4-FBFE229CC710">5307766A-5863-5AAD-9DC4-FBFE229CC710</uri>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>12</month>
          <year>2023</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>01</month>
          <year>2024</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Ghada Hamid Naji, Fatima J. Al Gawhari</copyright-statement>
        <license license-type="creative-commons-attribution" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <label>Abstract</label>
        <p><bold>Background</bold>: Bilosomes are lipid vesicles that exhibit flexibility and deformability. They consist of phospholipids and amphiphilic bile salts. Compared to the normal vesicular systems such as liposomes and niosomes, bilosomes provide several notable advantages, including simplified manufacturing, cost-effectiveness, and enhanced stability.</p>
        <p><bold>Aim</bold>: The main objective of the present work was to evaluate the effect of different bile salts on the physical properties that include entrapment efficiency, vesicle size, and polydispersity index(<abbrev xlink:title="polydispersity index" id="ABBRID0ETD">PDI</abbrev>). In addition, <italic>in vitro</italic> drug release for nisoldipine (<abbrev xlink:title="nisoldipine" id="ABBRID0EZD">NSD</abbrev>) loaded bilosomes was evaluated.</p>
        <p><bold>Methods</bold>: Nisoldipine-loaded bilosomes were made using a thin film hydration technique. Cholesterol along with surfactant (span 60) was employed, and the formulation also contained several different bile salts, including sodium deoxycholate (<abbrev xlink:title="sodium deoxycholate" id="ABBRID0EBE">SDC</abbrev>), sodium glycocholate (<abbrev xlink:title="sodium glycocholate" id="ABBRID0EFE">SGC</abbrev>), and sodium taurocholate (<abbrev xlink:title="sodium taurocholate" id="ABBRID0EJE">STC</abbrev>).</p>
        <p><bold>Results</bold>: The developed <abbrev xlink:title="nisoldipine" id="ABBRID0ERE">NSD</abbrev> bilosomes exhibited an entrapment efficiency ranging from 44.2 ± 0.3 to 82.36 ± 0.80% and a vesicle size diameter in the nanometric dimensions (166 ± 1.83 to 237.8 ± 3.3 nm). An in-vitro release study revealed that formulas prepared with <abbrev xlink:title="sodium deoxycholate" id="ABBRID0E5E">SDC</abbrev> bile salts showed higher drug release than <abbrev xlink:title="sodium glycocholate" id="ABBRID0ECF">SGC</abbrev> and <abbrev xlink:title="sodium taurocholate" id="ABBRID0EGF">STC</abbrev> formulas.</p>
        <p>Increasing the bile salt amount from 5 mg to 10 mg increases entrapment efficiency with increasing vesicle size. Further increase in bile salt led to decreased entrapment efficiency with increased vesicle size. <abbrev xlink:title="sodium deoxycholate" id="ABBRID0E5F">SDC</abbrev> gives the best result in terms of entrapment efficiency and acceptable size. <abbrev xlink:title="sodium taurocholate" id="ABBRID0ELG">STC</abbrev> provides the largest particle size due to its high molecular weight compared to <abbrev xlink:title="sodium glycocholate" id="ABBRID0EPG">SGC</abbrev> and <abbrev xlink:title="sodium deoxycholate" id="ABBRID0ETG">SDC</abbrev>.</p>
        <p><bold>Conclusion</bold>: The <abbrev xlink:title="sodium deoxycholate" id="ABBRID0E2G">SDC</abbrev> bile salt component is better suited for manufacturing <abbrev xlink:title="nisoldipine" id="ABBRID0E6G">NSD</abbrev> bilosomes. This is because this component yields the best results regarding high entrapment efficiency, nano size, and prolonged drug release.</p>
      </abstract>
      <kwd-group>
        <label>Keywords</label>
        <kwd>Bilosomes</kwd>
        <kwd>entrapment efficiency</kwd>
        <kwd>sodium deoxycholate</kwd>
        <kwd>sodium taurocholate</kwd>
        <kwd>thin film hydration</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <sec sec-type="Citation" id="SECID0E4H">
        <title>Citation</title>
        <p>Naji GH, Al Gawhari FJ (2024) Evaluation of types and concentration of bile salts impact on physical properties of nisoldipine-loaded bilosomes. Pharmacia 71: 1–7. <ext-link xlink:href="10.3897/pharmacia.71.e116917" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3897/pharmacia.71.e116917</ext-link></p>
      </sec>
    </notes>
  </front>
  <body>
    <sec sec-type="Introduction" id="SECID0EJAAC">
      <title>Introduction</title>
      <p>Drugs are ineffective until a safe method of delivering them to the circulatory system or a site-specific delivery system is discovered, despite the many advances in pharmaceutical research (<xref ref-type="bibr" rid="B15">Drais and Hussein 2022</xref>).</p>
      <p>Due to their diverse advantages, lipid-based vesicular systems play a crucial role in pharmaceutical delivery. The advantages encompass the ability to encapsulate both lipophilic and hydrophilic molecules, along with the capability to overcome various challenges such as drug insolubility and drug loading, so bilosomes are preferred over another lipid-based vesicular system (<xref ref-type="bibr" rid="B23">Kharouba et al. 2022</xref>).</p>
      <p>Bilosomes refer to lipid vesicles that exhibit flexibility and deformability, mostly comprised of phospholipids and amphiphilic bile salts. In contrast to typical vesicular systems such as liposomes and niosomes, bilosomes provide several notable advantages, including simplified manufacturing processes, cost-effectiveness, and enhanced stability (<xref ref-type="bibr" rid="B22">Khafagy et al. 2023</xref>).</p>
      <p>They resist degradation by enzymatic GIT due to the presence of bile salt in the vesicle membrane, which enhances penetration and makes oral delivery more effective (<xref ref-type="bibr" rid="B11">Anon 2020</xref>; <xref ref-type="bibr" rid="B36">Waglewska et al. 2020</xref>).</p>
      <p>Bilosome formulations frequently use non-ionic surfactants, such as span series, bile salts, and cholesterol. These materials are widely regarded as harmless and have been demonstrated to be fully biocompatible and biodegradable when used to create bilosomes. (<xref ref-type="bibr" rid="B12">Binsuwaidan et al. 2022</xref>).</p>
      <p>Bile salts are chemicals that can solubilize and enhance the penetration of substances. They are utilized extensively because they are not toxic and are therefore compatible with biological systems (<xref ref-type="bibr" rid="B37">Zafar et al. 2021</xref>).</p>
      <p>Bile salt gives the vesicles a negative charge, increasing their storage stability and encouraging drug absorption through the M-cells in the Peyer’s patch. After that, cellular activities continue into the underlying lymphoid tissue, preventing hepatic first-pass metabolism and facilitating drug transport into the intestinal lymphatic system (<xref ref-type="bibr" rid="B19">Ismail et al. 2022</xref>). Patient compliance and adherence improved due to reduced frequent doses (<xref ref-type="bibr" rid="B21">Kadhim and Rajab 2022</xref>).</p>
      <p>Different types of bile salts can be used to prepare bilosomes. Some examples include sodium glycocholate (<abbrev xlink:title="sodium glycocholate" id="ABBRID0EBCAC">SGC</abbrev>), sodium deoxycholate (<abbrev xlink:title="sodium deoxycholate" id="ABBRID0EFCAC">SDC</abbrev>), sodium taurocholate (<abbrev xlink:title="sodium taurocholate" id="ABBRID0EJCAC">STC</abbrev>), and sodium taurodeoxycholate (<abbrev xlink:title="sodium taurodeoxycholate" id="ABBRID0ENCAC">STDC</abbrev>) (<xref ref-type="bibr" rid="B29">Palekar-Shanbhag et al. 2020</xref>).</p>
      <p>Nisoldipine (<abbrev xlink:title="Nisoldipine" id="ABBRID0EXCAC">NSD</abbrev>) (C20H24N2O6) is a calcium channel blocker belonging to the dihydropyridine family that stops calcium from entering cardiac and vascular smooth muscle transmembrane. When calcium ions pass through certain ion channels, the heart contracts. So if this channel (Ca<sup>++</sup> channel) is blocked this leads to arterioles dilation (<xref ref-type="bibr" rid="B13">Chaudhari et al. 2019</xref>) and decreases the contraction of cardiac muscles. For that reason it is primarily employed in the management of cardiovascular disorders, such as the treatment of hypertension, cardiovascular disease, and several types of angina, such as prinzmetal or variant angina. The half-life is seen to be long, between 7 and 12 hours.</p>
      <p>The average duration required to reach the highest levels of the drug in the bloodstream has been documented as 9.2 ± 5.1 hours (<xref ref-type="bibr" rid="B27">Nekkanti et al. 2016</xref>).</p>
      <p>The drug Nisoldipine belongs to Biopharmaceutical classification system (BCS) as (class II drug;that means that it has low solubility and high permeability properties. Furthermore, nisoldipine undergoes first-pass metabolism, before reaching the site of drug action and only 5% of it is used by the body (<xref ref-type="bibr" rid="B4">Al-Edhari and Al Gawhari 2023</xref>). Furthermore, <abbrev xlink:title="nisoldipine" id="ABBRID0EJDAC">NSD</abbrev>’s low water solubility (5.77 × 10−3 g/L) led to poor dissolution and low bioavailability (<xref ref-type="bibr" rid="B14">Chavan et al. 2020</xref>; <xref ref-type="bibr" rid="B18">Gasmi et al. 2023</xref>).</p>
      <p>The present work was designed to develop and formulate <abbrev xlink:title="nisoldipine" id="ABBRID0EXDAC">NSD</abbrev> bilosomes using different types of bile salts and assess the effect of these salts on bilosomes properties, including entrapment efficiency, particle size, <abbrev xlink:title="polydispersity index" id="ABBRID0EEEAC">PDI</abbrev>, and drug release.</p>
    </sec>
    <sec sec-type="methods" id="SECID0EIEAC">
      <title>Methods and methods</title>
      <sec sec-type="Materials" id="SECID0EMEAC">
        <title>Materials</title>
        <p>We bought nisodipine from Lee Chemicals in India (patch number 293). We bought cholesterol, bile salts (<abbrev xlink:title="sodium deoxycholate" id="ABBRID0ESEAC">SDC</abbrev>, <abbrev xlink:title="sodium glycocholate" id="ABBRID0EWEAC">SGC</abbrev>, and <abbrev xlink:title="sodium taurocholate" id="ABBRID0E1EAC">STC</abbrev>), and surfactants (Span 60) from Hyperchem Limited company Chemicals in India. Analytical grade solvents and other compounds were all used in the current experiment.</p>
      </sec>
      <sec sec-type="Preparation of nisoldipine nano-bilosomes" id="SECID0E5EAC">
        <title>Preparation of nisoldipine nano-bilosomes</title>
        <p>In order to create <abbrev xlink:title="nisoldipine" id="ABBRID0EEFAC">NSD</abbrev> bilosomes, the <abbrev xlink:title="nisoldipine" id="ABBRID0EIFAC">NSD</abbrev> was dissolved in an appropriate size about (ten ml) of chloroform in a flask. Additionally, cholesterol and a specified amount of surfactant (span 60) were also dissolved during this process (<xref ref-type="bibr" rid="B5">Al-Hussaniy et al. 2023</xref>).</p>
        <p>To ensure that the organic solvent was completely eliminated, it was evaporated under a vacuum at 60 °C using a rotary evaporator (Buchi R-210 Rotavapor System, Germany) set to 90 rpm for 30 minutes. After that, 10 mL of phosphate buffer (pH 7.4) containing bile salts was used to hydrate the thin, dry film that had developed on the inner wall of the flask.</p>
        <p>To create Nisoldipine loaded bilosomes, the resulting hydrated dispersion of BS was sonicated in a bath sonicator (Powersonic 410, Hwashin Technology, Korea). While the completed combination was being kept in the refrigerator, it was observed for a number of criteria (<xref ref-type="bibr" rid="B2">Ahad et al. 2018</xref>) see Table <xref ref-type="table" rid="T1">1</xref>.</p>
        <table-wrap id="T1" position="float" orientation="portrait">
          <label>Table 1.</label>
          <caption>
            <p>Composition of various <abbrev xlink:title="nisoldipine" id="ABBRID0EEGAC">NSD</abbrev> bilosomes formulations.</p>
          </caption>
          <table id="TID0ELLAG" rules="all">
            <tbody>
              <tr>
                <th rowspan="1" colspan="1">Formula No.</th>
                <th rowspan="1" colspan="1"><abbrev xlink:title="nisoldipine" id="ABBRID0EUGAC">NSD</abbrev> (mg)</th>
                <th rowspan="1" colspan="1">Cholesterol (mg)</th>
                <th rowspan="1" colspan="1">Span 60 (mg)</th>
                <th rowspan="1" colspan="1"><abbrev xlink:title="sodium deoxycholate" id="ABBRID0ECHAC">SDC</abbrev> (mg)</th>
                <th rowspan="1" colspan="1"><abbrev xlink:title="sodium glycocholate" id="ABBRID0EKHAC">SGC</abbrev> (mg)</th>
                <th rowspan="1" colspan="1"><abbrev xlink:title="sodium taurocholate" id="ABBRID0ESHAC">STC</abbrev> (mg)</th>
                <th rowspan="1" colspan="1">Sonication time (min)</th>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <bold>F1</bold>
                </td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">80</td>
                <td rowspan="1" colspan="1">240</td>
                <td rowspan="1" colspan="1">5</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">10</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <bold>F2</bold>
                </td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">80</td>
                <td rowspan="1" colspan="1">240</td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">10</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <bold>F3</bold>
                </td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">80</td>
                <td rowspan="1" colspan="1">240</td>
                <td rowspan="1" colspan="1">20</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">10</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <bold>F4</bold>
                </td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">80</td>
                <td rowspan="1" colspan="1">240</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">5</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">10</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <bold>F5</bold>
                </td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">80</td>
                <td rowspan="1" colspan="1">240</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">10</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <bold>F6</bold>
                </td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">80</td>
                <td rowspan="1" colspan="1">240</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">20</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">10</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <bold>F7</bold>
                </td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">80</td>
                <td rowspan="1" colspan="1">240</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">5</td>
                <td rowspan="1" colspan="1">10</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <bold>F8</bold>
                </td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">80</td>
                <td rowspan="1" colspan="1">240</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">10</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">
                  <bold>F9</bold>
                </td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">80</td>
                <td rowspan="1" colspan="1">240</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">/</td>
                <td rowspan="1" colspan="1">20</td>
                <td rowspan="1" colspan="1">10</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec sec-type="Characterization and evaluation of NSD loaded bilosomes" id="SECID0EVPAC">
        <title>Characterization and evaluation of <abbrev xlink:title="nisoldipine" id="ABBRID0E1PAC">NSD</abbrev> loaded bilosomes</title>
        <sec sec-type="Particle size and Poly Dispersity Index (PDI)" id="SECID0E5PAC">
          <title>
            <italic>Particle size and Poly Dispersity Index (<abbrev xlink:title="polydispersity index" id="ABBRID0EGAAE">PDI</abbrev>)</italic>
          </title>
          <p>The Zetasizer device from Malvern (Malvern UK) was utilized to perform the particle size measurement. This device is capable of performing dynamic light scattering, which involves estimating the intensity of light scattered by the particles in the tested sample as a meaning of time while maintaining a temperature of 25 °C and a scattering angle of 90° (<xref ref-type="bibr" rid="B8">Al-Mahmood and Abd Alhammid 2022</xref>; <xref ref-type="bibr" rid="B9">Al-Sawaf and Jalal 2023</xref>).</p>
          <p>The real refractive index and the imaginary refractive index were set at 1.456 and 0.01, respectively. It was determined that a homogenous distribution of vesicles existed when the <abbrev xlink:title="polydispersity index" id="ABBRID0ETAAE">PDI</abbrev> value was less than 0.1, but a larger globule dispersion was indicated by large values that approached 1 (<xref ref-type="bibr" rid="B30">Rajab 2022</xref>).</p>
        </sec>
        <sec sec-type="Entrapment efficiency" id="SECID0E2AAE">
          <title>
            <italic>Entrapment efficiency</italic>
          </title>
          <p>As an indirect technique, the %EE of <abbrev xlink:title="nisoldipine" id="ABBRID0ENBAE">NSD</abbrev> in the bilosomes may be resolute by measuring un-entrapped <abbrev xlink:title="nisoldipine" id="ABBRID0ERBAE">NSD</abbrev> in the dispersion media. One milliliter of bilosomes was put in a centrifugation tube and spun at 16,000 rpm for an hour at 4 °C using a cold centrifuge. The drug was quantitively analyzed with a UV-VIS spectrophotometer set at wave length about 237 nm after the resultant supernatant was separated from the rest of the sample and diluted with PBS. Therefore, %EE was considered since we used this equation (<xref ref-type="bibr" rid="B7">Al-Mahallawi et al. 2015</xref>):</p>
          <p>
            <mml:math id="M1">
              <mml:mi>E</mml:mi>
              <mml:mi>E</mml:mi>
              <mml:mo>%</mml:mo>
              <mml:mo>=</mml:mo>
              <mml:mfrac>
                <mml:mrow>
                  <mml:mi>T</mml:mi>
                  <mml:mi>o</mml:mi>
                  <mml:mi>t</mml:mi>
                  <mml:mi>a</mml:mi>
                  <mml:mi>l</mml:mi>
                  <mml:mspace width="0.5em"/>
                  <mml:mi>a</mml:mi>
                  <mml:mi>m</mml:mi>
                  <mml:mi>o</mml:mi>
                  <mml:mi>u</mml:mi>
                  <mml:mi>n</mml:mi>
                  <mml:mi>t</mml:mi>
                  <mml:mspace width="0.5em"/>
                  <mml:mi>o</mml:mi>
                  <mml:mi>f</mml:mi>
                  <mml:mspace width="0.5em"/>
                  <mml:mi>d</mml:mi>
                  <mml:mi>r</mml:mi>
                  <mml:mi>u</mml:mi>
                  <mml:mi>g</mml:mi>
                  <mml:mo>-</mml:mo>
                  <mml:mi>A</mml:mi>
                  <mml:mi>m</mml:mi>
                  <mml:mi>o</mml:mi>
                  <mml:mi>u</mml:mi>
                  <mml:mi>n</mml:mi>
                  <mml:mi>t</mml:mi>
                  <mml:mspace width="0.5em"/>
                  <mml:mi>o</mml:mi>
                  <mml:mi>f</mml:mi>
                  <mml:mspace width="0.5em"/>
                  <mml:mi>f</mml:mi>
                  <mml:mi>r</mml:mi>
                  <mml:mi>e</mml:mi>
                  <mml:mi>e</mml:mi>
                  <mml:mspace width="0.5em"/>
                  <mml:mi>d</mml:mi>
                  <mml:mi>r</mml:mi>
                  <mml:mi>u</mml:mi>
                  <mml:mi>g</mml:mi>
                </mml:mrow>
                <mml:mrow>
                  <mml:mi>T</mml:mi>
                  <mml:mi>o</mml:mi>
                  <mml:mi>t</mml:mi>
                  <mml:mi>a</mml:mi>
                  <mml:mi>l</mml:mi>
                  <mml:mspace width="0.5em"/>
                  <mml:mi>a</mml:mi>
                  <mml:mi>m</mml:mi>
                  <mml:mi>o</mml:mi>
                  <mml:mi>u</mml:mi>
                  <mml:mi>n</mml:mi>
                  <mml:mi>t</mml:mi>
                  <mml:mspace width="0.5em"/>
                  <mml:mi>o</mml:mi>
                  <mml:mi>f</mml:mi>
                  <mml:mspace width="0.5em"/>
                  <mml:mi>d</mml:mi>
                  <mml:mi>r</mml:mi>
                  <mml:mi>u</mml:mi>
                  <mml:mi>g</mml:mi>
                </mml:mrow>
              </mml:mfrac>
              <mml:mo>×</mml:mo>
              <mml:mn>100</mml:mn>
            </mml:math>
          </p>
        </sec>
        <sec sec-type="Fourier Transform Infrared Spectroscopy (FTIR)" id="SECID0EZBAE">
          <title>
            <italic>Fourier Transform Infrared Spectroscopy (<abbrev xlink:title="Fourier Transform Infrared Spectroscopy" id="ABBRID0EACAE">FTIR</abbrev>)</italic>
          </title>
          <p>Fourier Transform Infrared Spectroscopy (<abbrev xlink:title="Fourier Transform Infrared Spectroscopy" id="ABBRID0EHCAE">FTIR</abbrev>) was conducted in order to validate the purity of the medicine and ascertain its compatibility with other excipients. The sample was combined with dry potassium bromide (<abbrev xlink:title="dry potassium bromide" id="ABBRID0ELCAE">KBr</abbrev>) in a fixed ratio of 1:10, and subsequently, the resulting mixture was compacted into pellets. The range of samples was measured from 4000 cm<sup>-1</sup> to 400 cm<sup>-1</sup>. The analysis was conducted on the pure drug, a physical mixture of the drug, cholesterol, span 60, and bile salt, as well as the selected bilosome formulation (<xref ref-type="bibr" rid="B20">Jassim et al. 2021</xref>).</p>
        </sec>
      </sec>
      <sec sec-type="In vitro drug release" id="SECID0EXCAE">
        <title><italic>In vitro</italic> drug release</title>
        <p>Different bilosmoe formulations, each made with a different type of bile salts, were subjected to <italic>in vitro</italic> drug release testing. A volume of two milliliters was extracted from the formulae, which were subsequently transferred into dialysis baggage that had been soaked overnight. Subsequently, the dialysis bags were introduced into a type two dissolving apparatus, specifically the paddle type, operating at a temperature of 37 ± 0.2 °C and a rotation speed of 50 rpm.</p>
        <p>The release medium employed consisted of 250 ml of a phosphate-buffered saline (PBS) solution, including 0.75% w/v sodium lauryl sulfate (<abbrev xlink:title="sodium lauryl sulfate" id="ABBRID0EEDAE">SLS</abbrev>), with the intention of establishing a sink condition.</p>
        <p>Samples of three milliliters were removed at predefined time intervals (1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24 hours). These were then changed with the same volume with fresh Buffer solution to ensure the maintenance of sink condition. The UV/VIS spectrophotometer was utilized to measure the cumulative release of <abbrev xlink:title="nisoldipine" id="ABBRID0EKDAE">NSD</abbrev> at a wavelength of 237 nm (<xref ref-type="bibr" rid="B32">Saifi et al. 2020</xref>).</p>
      </sec>
      <sec sec-type="Statistical analysis" id="SECID0ESDAE">
        <title>Statistical analysis</title>
        <p>The results of the experimental study were presented as the mean of triplicate models ± standard deviation (SD). These results were analyzed using a one-way ANOVA test to assess the statistical significance of the changes in the applied factors (<xref ref-type="bibr" rid="B10">Altalebi et al. 2023</xref>).</p>
        <p>A significance level of p &lt; 0.05 was used to determine if the observed changes were statistically significant, while a significance level of p &gt; 0.05 indicated that the changes were not statistically significant (<xref ref-type="bibr" rid="B28">Noor and Ghareeb 2021</xref>; <xref ref-type="bibr" rid="B35">Shaaban et al. 2023</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="Results and discussion" id="SECID0EGEAE">
      <title>Results and discussion</title>
      <p>The <abbrev xlink:title="nisoldipine" id="ABBRID0EMEAE">NSD</abbrev> loaded bilosomes that had already been made were analyzed for their entrapment efficiency. Results in Table <xref ref-type="table" rid="T2">2</xref> revealed that entrapment efficiency increases significantly from 60.68% in F5 (<abbrev xlink:title="sodium glycocholate" id="ABBRID0EGFAE">SGC</abbrev>) into 73.22% and 82.36% in F8 (<abbrev xlink:title="sodium taurocholate" id="ABBRID0EKFAE">STC</abbrev>) and F2 (<abbrev xlink:title="sodium deoxycholate" id="ABBRID0EOFAE">SDC</abbrev>) respectively.</p>
      <table-wrap id="T2" position="float" orientation="portrait">
        <label>Table 2.</label>
        <caption>
          <p><bold>Physical</bold> properties of <abbrev xlink:title="nisoldipine" id="ABBRID0E4FAE">NSD</abbrev> bilosomes.</p>
        </caption>
        <table id="TID0EGYAG" rules="all">
          <tbody>
            <tr>
              <th rowspan="1" colspan="1">Formula No.</th>
              <th rowspan="1" colspan="1">Vesicle size (VS)</th>
              <th rowspan="1" colspan="1">
                <abbrev xlink:title="polydispersity index" id="ABBRID0EQGAE">PDI</abbrev>
              </th>
              <th rowspan="1" colspan="1">
                Entrapment Efficiency (EE%)</th>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>F1</bold>
              </td>
              <td rowspan="1" colspan="1">166 ± 1.83</td>
              <td rowspan="1" colspan="1">0.33 ± 0.3</td>
              <td rowspan="1" colspan="1">71 ± 0.42%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>F2</bold>
              </td>
              <td rowspan="1" colspan="1">175.73 ± 0.39</td>
              <td rowspan="1" colspan="1">0.19 ± 0.03</td>
              <td rowspan="1" colspan="1">82.36 ± 0.80%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>F3</bold>
              </td>
              <td rowspan="1" colspan="1">211.5 ± 0.74</td>
              <td rowspan="1" colspan="1">0.19 ± 0.081</td>
              <td rowspan="1" colspan="1">60.13 ± 0.78%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>F4</bold>
              </td>
              <td rowspan="1" colspan="1">177.9 ± 1.24</td>
              <td rowspan="1" colspan="1">0.19 ± 0.01</td>
              <td rowspan="1" colspan="1">49.37 ± 1.26%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>F5</bold>
              </td>
              <td rowspan="1" colspan="1">185.7 ± 0.96</td>
              <td rowspan="1" colspan="1">0.27 ± 0.07</td>
              <td rowspan="1" colspan="1">60.68 ± 0.78%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>F6</bold>
              </td>
              <td rowspan="1" colspan="1">230.1 ± 3.5</td>
              <td rowspan="1" colspan="1">0.26 ± 0.01</td>
              <td rowspan="1" colspan="1">44.2 ± 0.3%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>F7</bold>
              </td>
              <td rowspan="1" colspan="1">186.96 ± 0.32</td>
              <td rowspan="1" colspan="1">0.29 ± 0.028</td>
              <td rowspan="1" colspan="1">60.13 ± 0.35%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>F8</bold>
              </td>
              <td rowspan="1" colspan="1">208.36 ± 0.9</td>
              <td rowspan="1" colspan="1">0.16 ± 0.037</td>
              <td rowspan="1" colspan="1">73.22 ± 0.59%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>F9</bold>
              </td>
              <td rowspan="1" colspan="1">263 ± 2.4</td>
              <td rowspan="1" colspan="1">0.27 ± 0.03</td>
              <td rowspan="1" colspan="1">52.55 ± 1.01%</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>This could be due to lower HLB value (higher hydrophobicity) of <abbrev xlink:title="sodium deoxycholate" id="ABBRID0EQLAE">SDC</abbrev> (HLB=16) compared to that of <abbrev xlink:title="sodium glycocholate" id="ABBRID0EULAE">SGC</abbrev> and <abbrev xlink:title="sodium taurocholate" id="ABBRID0EYLAE">STC</abbrev> possessing higher HLB values (23.1) and (22.1) respectively. The higher hydrophobicity made it easier for the hydrophobic drug <abbrev xlink:title="nisoldipine" id="ABBRID0E3LAE">NSD</abbrev> to get into the core of the bilayer, which led to a higher EE (<xref ref-type="bibr" rid="B16">El-Nabarawi et al. 2020</xref>), as seen in Fig. <xref ref-type="fig" rid="F1">1</xref>.</p>
      <fig id="F1" position="float" orientation="portrait">
        <object-id content-type="doi">10.3897/pharmacia.71.e116917.figure1</object-id>
        <object-id content-type="arpha">E326CE06-AC2D-5425-A7BE-0A078E084ED5</object-id>
        <label>Figure 1.</label>
        <caption>
          <p>Effect of type of bile salts on entrapment efficiency (p &lt; 0.05).</p>
        </caption>
        <graphic xlink:href="pharmacia-71-e116917-g001.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_982044.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/982044</uri>
        </graphic>
      </fig>
      <p>Increasing bile salts from 5 to 10 mg Fig. <xref ref-type="fig" rid="F2">2</xref>, entrapment efficiency increase significantly from 71% to 82% in F1 and F2 respectively. <abbrev xlink:title="sodium deoxycholate" id="ABBRID0ENNAE">SDC</abbrev> has surface active property and is integrated into bilayer membrane surfaces, enhancing lipid membrane flexibility and drug solubility, increasing entrapment efficiency (<xref ref-type="bibr" rid="B37">Zafar et al. 2021</xref>).</p>
      <fig id="F2" position="float" orientation="portrait">
        <object-id content-type="doi">10.3897/pharmacia.71.e116917.figure2</object-id>
        <object-id content-type="arpha">89142414-905E-5A57-AA11-17EB255E8F52</object-id>
        <label>Figure 2.</label>
        <caption>
          <p>Effect of Bile salt concentration on Entrapment Efficiency (p &lt; 0.05).</p>
        </caption>
        <graphic xlink:href="pharmacia-71-e116917-g002.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_982045.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/982045</uri>
        </graphic>
      </fig>
      <p>Further increase of bile salt concentration leads to significant decrease in EE from 82.36% in F2 into 60.13% in F3 because high bile salt content enhances the possibility of acting as a solubilizing surfactant and lowers vesicle compactness, facilitating drug leakage and decreasing EE% (<xref ref-type="bibr" rid="B38">Zakaria et al. 2021</xref>).</p>
      <p>According to the data in Table <xref ref-type="table" rid="T2">2</xref>, the bilosomes’ particle size distribution index (<abbrev xlink:title="particle size distribution index" id="ABBRID0E4OAE">PDI</abbrev>) ranged from 0.16 ± 0.037 to 0.33 ± 0.3 (for formulations F8 and F1), indicating a limited size distribution. According to the results of an ANOVA test, the <abbrev xlink:title="polydispersity index" id="ABBRID0EBPAE">PDI</abbrev> of the produced vesicles was not substantially (p &gt; 0.05) affected by the conditions that were investigated.</p>
      <p>Increasing the concentration of bile salt from 5 mg to 10 mg and to 20 mg leads to a significant increase in vesicle size for all types of bile salts (p &lt; 0.05) as seen in Fig. <xref ref-type="fig" rid="F3">3</xref>.</p>
      <fig id="F3" position="float" orientation="portrait">
        <object-id content-type="doi">10.3897/pharmacia.71.e116917.figure3</object-id>
        <object-id content-type="arpha">1F83AF8E-8C73-5248-A068-E6FCA5A7BDDC</object-id>
        <label>Figure 3.</label>
        <caption>
          <p>Effect of different concentrations of different bile salts on vesicle size (p &lt; 0.05).</p>
        </caption>
        <graphic xlink:href="pharmacia-71-e116917-g003.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_982046.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/982046</uri>
        </graphic>
      </fig>
      <p>That’s because bile salt, when concentrated to a high level, tends to agglomerate, and that’s exactly what happened here. Anionic bile salts and their steroid structure increase vesicle size in two ways: (i) by increasing the volume of the aqueous core and (ii) by increasing the steric repulsive power among bilosome bilayers, which may increase bilosome bulkiness (<xref ref-type="bibr" rid="B25">Mahmoud et al. 2022</xref>).</p>
      <p>The increase in vesicle size was determined to be as follows, based on the bile salts that were investigated: <abbrev xlink:title="sodium taurocholate" id="ABBRID0E6PAE">STC</abbrev> &gt; <abbrev xlink:title="sodium glycocholate" id="ABBRID0EDQAE">SGC</abbrev> &gt; <abbrev xlink:title="sodium deoxycholate" id="ABBRID0EHQAE">SDC</abbrev>. It’s possible that the variation in vesicle size is caused by a difference in the structure of the bile salt that was used (<xref ref-type="bibr" rid="B1">Abdelbary et al. 2016</xref>). <abbrev xlink:title="sodium glycocholate" id="ABBRID0EPQAE">SGC</abbrev> (487.6 g/mol) and <abbrev xlink:title="sodium deoxycholate" id="ABBRID0ETQAE">SDC</abbrev> (414.56 g/mol) based bilosomal vesicles may have created smaller vesicle size when compared to the bulkier <abbrev xlink:title="sodium taurocholate" id="ABBRID0EXQAE">STC</abbrev> (537.69 g/mol), which may have resulted in a larger size (<xref ref-type="bibr" rid="B26">Mohsen et al. 2020</xref>), Fig. <xref ref-type="fig" rid="F4">4</xref> showed that (F7–F9) prepared with <abbrev xlink:title="sodium taurocholate" id="ABBRID0EDRAE">STC</abbrev> give significantly larger vesicle size as compared with (F4–F6) and (F1–F3) prepared with <abbrev xlink:title="sodium glycocholate" id="ABBRID0EHRAE">SGC</abbrev> and <abbrev xlink:title="sodium deoxycholate" id="ABBRID0ELRAE">SDC</abbrev> respectively.</p>
      <fig id="F4" position="float" orientation="portrait">
        <object-id content-type="doi">10.3897/pharmacia.71.e116917.figure4</object-id>
        <object-id content-type="arpha">32722272-11C3-5AAD-AE1F-A6B8E45F838C</object-id>
        <label>Figure 4.</label>
        <caption>
          <p>Effect of bile salts kinds on vesicle dimensions (p &lt; 0.05).</p>
        </caption>
        <graphic xlink:href="pharmacia-71-e116917-g004.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_982047.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/982047</uri>
        </graphic>
      </fig>
      <p>Three formulas, F2, F5, and F8 were selected to do <italic>in vitro</italic> drug release according to EE% and types of bile salt, to determine the effect of types of bile salt on the drug release percentage of <abbrev xlink:title="nisoldipine" id="ABBRID0E6RAE">NSD</abbrev> from bilosomes.</p>
      <p>The bilosome formulas prepared using <abbrev xlink:title="sodium deoxycholate" id="ABBRID0EFSAE">SDC</abbrev> F3 showed a higher % drug release (97%) compared to the corresponding bilosome formulas F5 (93.5%) and F8 (87.45%) prepared with <abbrev xlink:title="sodium glycocholate" id="ABBRID0EJSAE">SGC</abbrev> and <abbrev xlink:title="sodium taurocholate" id="ABBRID0ENSAE">STC</abbrev>, respectively at the end of 24 hr, Fig. <xref ref-type="fig" rid="F5">5</xref>.</p>
      <fig id="F5" position="float" orientation="portrait">
        <object-id content-type="doi">10.3897/pharmacia.71.e116917.figure5</object-id>
        <object-id content-type="arpha">6BB1F949-C1A7-5409-B959-9595E6932873</object-id>
        <label>Figure 5.</label>
        <caption>
          <p>In vitro release profile of <abbrev xlink:title="nisoldipine" id="ABBRID0E4SAE">NSD</abbrev> from different formulas (F2, F5 and F8) along with pure drug suspension.</p>
        </caption>
        <graphic xlink:href="pharmacia-71-e116917-g005.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_982048.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/982048</uri>
        </graphic>
      </fig>
      <p>Release studies show biphasic drug efflux from bilosomal preparations. The initial phase exhibited a prompt and intense release of the drug, primarily resulting from the detachment of the drug molecules that were adsorbed onto the outer surface of the bilosome vesicles. This was followed by a subsequent phase characterized by a gradual and prolonged release of the drug over an extended duration. This sustained release is attributed to the bilosomes’ ability to function as a reservoir for the drug, facilitating its controlled and continuous release (<xref ref-type="bibr" rid="B34">Salim et al. 2022</xref>; <xref ref-type="bibr" rid="B24">Kumar et al. 2023</xref>).</p>
      <p>In addition to improving penetration by integrating itself into the bilayer membrane, <abbrev xlink:title="sodium deoxycholate" id="ABBRID0EOTAE">SDC</abbrev> is able to increase the fluidity and flexibility of the vesicle bilayer, which in turn makes drug seepage simpler (<xref ref-type="bibr" rid="B33">Salem et al. 2022</xref>).</p>
      <p>The drug release from bilosomes containing <abbrev xlink:title="sodium taurocholate" id="ABBRID0EYTAE">STC</abbrev> was lower than that of <abbrev xlink:title="sodium glycocholate" id="ABBRID0E3TAE">SGC</abbrev>-containing bilosomes. The numerous hydrophobic methylene groups on the bilosome side chains during the <abbrev xlink:title="sodium taurocholate" id="ABBRID0EAUAE">STC</abbrev>’s conjugation with taurine account for this action, delaying medication release (Ali and Al-Akkam 2023).</p>
      <p>Since <abbrev xlink:title="nisoldipine" id="ABBRID0EGUAE">NSD</abbrev> is highly lipophilic, it would prefer to remain within the lipophilic system than release medium. Increased bile salt concentration had a positive effect on drug release which means increased drug release because it could enhance the fluidity of the bilayer and penetration enhancer effect (<xref ref-type="bibr" rid="B3">Ahmed et al. 2020</xref>; <xref ref-type="bibr" rid="B31">Rana et al. 2023</xref>).</p>
      <p>From the above results, F2 was the optimum formula in terms of small vesicle size with the higher entrapment efficiency along with best drug release, so <abbrev xlink:title="Fourier Transform Infrared Spectroscopy" id="ABBRID0E4UAE">FTIR</abbrev> was done to determine if there is a chemical interaction between their components.</p>
      <p>Fig. <xref ref-type="fig" rid="F6">6A</xref> displayed the <abbrev xlink:title="Fourier Transform Infrared Spectroscopy" id="ABBRID0EHVAE">FTIR</abbrev> for a physical combination, a pure medication, and a chosen formula. In the pure <abbrev xlink:title="nisoldipine" id="ABBRID0ELVAE">NSD</abbrev> spectra, the N-H stretching peak was located at 3318.40 cm<sup>−1,</sup> the C-O stretching peak at 1650.01 cm<sup>−1</sup>, the N-O stretching peak at 1526.25 cm<sup>−1</sup>, and the C=O stretching peak at 1211.37 cm<sup>−1.</sup> (<xref ref-type="bibr" rid="B17">Fu et al. 2017</xref>) .</p>
      <fig id="F6" position="float" orientation="portrait">
        <object-id content-type="doi">10.3897/pharmacia.71.e116917.figure6</object-id>
        <object-id content-type="arpha">857A7AAC-19BD-50B6-8718-DF8143D581F3</object-id>
        <label>Figure 6.</label>
        <caption>
          <p><abbrev xlink:title="Fourier Transform Infrared Spectroscopy" id="ABBRID0EDWAE">FTIR</abbrev> for A. Pure <abbrev xlink:title="nisoldipine" id="ABBRID0EHWAE">NSD</abbrev>; <bold>B.</bold> Physical Mixture; <bold>C.</bold> F2 <abbrev xlink:title="nisoldipine" id="ABBRID0EPWAE">NSD</abbrev> bilosome formula.</p>
        </caption>
        <graphic xlink:href="pharmacia-71-e116917-g006.jpg" position="float" orientation="portrait" xlink:type="simple" id="oo_982049.jpg">
          <uri content-type="original_file">https://binary.pensoft.net/fig/982049</uri>
        </graphic>
      </fig>
      <p>The physical mixture’s <abbrev xlink:title="Fourier Transform Infrared Spectroscopy" id="ABBRID0E1WAE">FTIR</abbrev> spectrum shows that the (C-O stretching vibration) has slightly shifted from 1650.01 cm<sup>-1</sup> to 1648.71 cm<sup>-1</sup>, while the other primary peaks have not altered. This suggests that <abbrev xlink:title="nisoldipine" id="ABBRID0ECXAE">NSD</abbrev> and the other ingredients needed to create bilosomes do not interact. There is no superimposition between fingerprint regions, which is evidence that there have been modifications in the physical character (Fig. <xref ref-type="fig" rid="F6">6</xref>) (Kadhim et al. 2020).</p>
    </sec>
    <sec sec-type="Conclusion" id="SECID0EKXAE">
      <title>Conclusion</title>
      <p>The bilosomal formulations effectively entrapped <abbrev xlink:title="nisoldipine" id="ABBRID0EQXAE">NSD</abbrev>. The physical features of <abbrev xlink:title="nisoldipine" id="ABBRID0EUXAE">NSD</abbrev> loading bilosomes were affected by the type and amount of bile salts used, including entrapment efficiency, vesicle size, polydispersity index, and in vitro drug release. <abbrev xlink:title="sodium deoxycholate" id="ABBRID0EBYAE">SDC</abbrev> was found to be better suited for the preparation of <abbrev xlink:title="nisoldipine" id="ABBRID0EFYAE">NSD</abbrev>-loading bilosomes. The <abbrev xlink:title="Fourier Transform Infrared Spectroscopy" id="ABBRID0EJYAE">FTIR</abbrev> analyses revealed no incompatibility between the medication and the other excipients in the mixture.</p>
      <p>The study’s results are encouraging since the <abbrev xlink:title="nisoldipine" id="ABBRID0EPYAE">NSD</abbrev>-BS results were in the nanosize range, allowing for optimal <abbrev xlink:title="nisoldipine" id="ABBRID0ETYAE">NSD</abbrev> delivery through excellent trapping and prolonged drug release.</p>
    </sec>
    <sec sec-type="Funding source" id="SECID0EXYAE">
      <title>Funding source</title>
      <p>The authors did not receive any source of funds.</p>
    </sec>
    <sec sec-type="Author contribution" id="SECID0E3YAE">
      <title>Author contribution</title>
      <p>Ghada Hamid Naji: conduct the research, draft writing, and experimental analysis; Fatima J. Al_Gawhari: supervision, revision, and proofreading.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>The authors express their gratitude to the College of Pharmacy at the University of Baghdad for supporting the project.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Abdelbary</surname><given-names>AA</given-names></name><name name-style="western"><surname>Abd-Elsalam</surname><given-names>WH</given-names></name><name name-style="western"><surname>Al-Mahallawi</surname><given-names>AM</given-names></name></person-group> (<year>2016</year>) <article-title>Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: In vitro characterization, ex vivo permeation and in vivo safety assessment.</article-title><source>International Journal of Pharmaceutics</source><volume>513</volume>: <fpage>688</fpage>–<lpage>696</lpage>. <ext-link xlink:href="10.1016/j.ijpharm.2016.10.006" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ijpharm.2016.10.006</ext-link></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Ahad</surname><given-names>A</given-names></name><name name-style="western"><surname>Raish</surname><given-names>M</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>A</given-names></name><name name-style="western"><surname>Al-Jenoobi</surname><given-names>FI</given-names></name><name name-style="western"><surname>Al-Mohizea</surname><given-names>AM</given-names></name></person-group> (<year>2018</year>) <article-title>Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats.</article-title><source>European journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences</source><volume>111</volume>: <fpage>409</fpage>–<lpage>417</lpage>. <ext-link xlink:href="10.1016/j.ejps.2017.10.012" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ejps.2017.10.012</ext-link></mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Ahmed</surname><given-names>S</given-names></name><name name-style="western"><surname>Kassem</surname><given-names>MA</given-names></name><name name-style="western"><surname>Sayed</surname><given-names>S</given-names></name></person-group> (<year>2020</year>) <article-title>Bilosomes as Promising Nanovesicular Carriers for Improved Transdermal Delivery: Construction, in vitro Optimization, ex vivo Permeation and in vivo Evaluation.</article-title><source>International Journal of Nanomedicine</source><volume>15</volume>: <fpage>9783</fpage>–<lpage>9798</lpage>. <ext-link xlink:href="10.2147/IJN.S278688" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2147/IJN.S278688</ext-link></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Al-Edhari</surname><given-names>GH</given-names></name><name name-style="western"><surname>Gawhari</surname><given-names>A</given-names></name></person-group> (<year>2023</year>) <article-title>Study the effect of formulation variables on preparation of nisoldipine loaded nano bilosomes.</article-title><source>Iraqi Journal of Pharmaceutical Sciences</source><volume>32</volume>: <fpage>271</fpage>–<lpage>282</lpage>. <ext-link xlink:href="10.31351/vol32issSuppl.pp271-282" ext-link-type="doi" xlink:type="simple">https://doi.org/10.31351/vol32issSuppl.pp271-282</ext-link></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Al-Hussaniy</surname><given-names>HA</given-names></name><name name-style="western"><surname>Аlmajidi</surname><given-names>YQ</given-names></name><name name-style="western"><surname>Oraibi</surname><given-names>AI</given-names></name><name name-style="western"><surname>Alkarawi</surname><given-names>AН</given-names></name></person-group> (<year>2023</year>) <article-title>Nanoemulsions as medicinal components in in soluble medicines.</article-title><source>Pharmacia</source><volume>70</volume>: <fpage>537</fpage>–<lpage>547</lpage>. <ext-link xlink:href="10.3897/pharmacia.70.e107131" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3897/pharmacia.70.e107131</ext-link></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Ali</surname><given-names>SK</given-names></name><name name-style="western"><surname>Ej</surname><given-names>A-A</given-names></name></person-group> (<year>2023</year>) <article-title>Effects of different types of bile salts on the physical properties of ropinirole-loaded.</article-title><source>Al-Rafidain Journal of Medical Sciences</source><volume>5</volume>: <fpage>134</fpage>–<lpage>142</lpage>. <ext-link xlink:href="10.54133/ajms.v5i.176" ext-link-type="doi" xlink:type="simple">https://doi.org/10.54133/ajms.v5i.176</ext-link></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Al-Mahallawi</surname><given-names>AM</given-names></name><name name-style="western"><surname>Abdelbary</surname><given-names>AA</given-names></name><name name-style="western"><surname>Aburahma</surname><given-names>MH</given-names></name></person-group> (<year>2015</year>) <article-title>Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.</article-title><source>International Journal of Pharmaceutics</source><volume>485</volume>: <fpage>329</fpage>–<lpage>340</lpage>. <ext-link xlink:href="10.1016/j.ijpharm.2015.03.033" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ijpharm.2015.03.033</ext-link></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Al-Mahmood</surname><given-names>AA</given-names></name><name name-style="western"><surname>Alhammid</surname><given-names>A</given-names></name></person-group> (<year>2022</year>) <article-title>Preparation and Ex-Vivo Evaluation of Stabilized Cefdinir Nanosuspension.</article-title><source>Pakistan Journal of Medical &amp; Health Sciences</source><volume>16</volume>: <fpage>1</fpage>–<lpage>6</lpage>. <ext-link xlink:href="10.53350/pjmhs20221612789" ext-link-type="doi" xlink:type="simple">https://doi.org/10.53350/pjmhs20221612789</ext-link></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Al-Sawaf</surname><given-names>OF</given-names></name><name name-style="western"><surname>Jalal</surname><given-names>F</given-names></name></person-group> (<year>2023</year>) <article-title>Novel probe sonication method for the preparation of meloxicam bilosomes for transdermal delivery: Part one.</article-title><source>Journal of Research in Medical and Dental Science</source><volume>11</volume>: <fpage>5</fpage>–<lpage>12</lpage>.</mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Altalebi</surname><given-names>RR</given-names></name><name name-style="western"><surname>Al-Hussaniy</surname><given-names>HA</given-names></name><name name-style="western"><surname>Al-Tameemi</surname><given-names>ZS</given-names></name><name name-style="western"><surname>Al-Zobaidy</surname><given-names>MA-H</given-names></name><name name-style="western"><surname>Albu-Rghaif</surname><given-names>AH</given-names></name><name name-style="western"><surname>Alkuraishy</surname><given-names>HM</given-names></name><name name-style="western"><surname>Hedeab</surname><given-names>GM</given-names></name><name name-style="western"><surname>Azam</surname><given-names>F</given-names></name><name name-style="western"><surname>Al-Samydai</surname><given-names>AM</given-names></name><name name-style="western"><surname>Naji</surname><given-names>MA</given-names></name></person-group> (<year>2023</year>) <article-title>Non-alcoholic fatty liver disease: relation to juvenile obesity, lipid profile, and hepatic enzymes.</article-title><source>Journal of Medicine and Life</source><volume>16</volume>: <fpage>42</fpage>–<lpage>47</lpage>. <ext-link xlink:href="10.25122/jml-2022-0091" ext-link-type="doi" xlink:type="simple">https://doi.org/10.25122/jml-2022-0091</ext-link></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation xlink:type="simple">Anon (<year>2020</year>) Formulation of flurbiprofen as microsponge drug delivery system. International Journal of Pharmaceutical Research 12. <ext-link xlink:href="10.31838/ijpr/2020.12.03.141" ext-link-type="doi" xlink:type="simple">https://doi.org/10.31838/ijpr/2020.12.03.141</ext-link></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Binsuwaidan</surname><given-names>R</given-names></name><name name-style="western"><surname>Sultan</surname><given-names>AA</given-names></name><name name-style="western"><surname>Negm</surname><given-names>WA</given-names></name><name name-style="western"><surname>Attallah</surname><given-names>NGM</given-names></name><name name-style="western"><surname>Alqahtani</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Hussein</surname><given-names>IA</given-names></name><name name-style="western"><surname>Shaldam</surname><given-names>MA</given-names></name><name name-style="western"><surname>El-Sherbeni</surname><given-names>SA</given-names></name><name name-style="western"><surname>Elekhnawy</surname><given-names>E</given-names></name></person-group> (<year>2022</year>) Bilosomes as nanoplatform for oral delivery and modulated in vivo antimicrobial activity of lycopene. Pharmaceuticals (Basel, Switzerland) 15: 1043. <ext-link xlink:href="10.3390/ph15091043" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/ph15091043</ext-link></mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Chaudhari</surname><given-names>GD</given-names></name><name name-style="western"><surname>Ghodgaonkar</surname><given-names>SA</given-names></name><name name-style="western"><surname>Vilegave</surname><given-names>KV</given-names></name></person-group> (<year>2019</year>) <article-title>Design, formulation and evaluation of extended release tablet containing nisoldipine.</article-title><source>Journal of Pharmacy and Pharmaceutics</source><volume>6</volume>: <fpage>1</fpage>–<lpage>9</lpage>.</mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Chavan</surname><given-names>RB</given-names></name><name name-style="western"><surname>Lodagekar</surname><given-names>A</given-names></name><name name-style="western"><surname>Yadav</surname><given-names>B</given-names></name><name name-style="western"><surname>Shastri</surname><given-names>NR</given-names></name></person-group> (<year>2020</year>) <article-title>Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.</article-title><source>Drug Delivery and Translational Research</source><volume>10</volume>: <fpage>903</fpage>–<lpage>918</lpage>. <ext-link xlink:href="10.1007/s13346-020-00775-8" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1007/s13346-020-00775-8</ext-link></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Drais</surname><given-names>HK</given-names></name><name name-style="western"><surname>Hussein</surname><given-names>AA</given-names></name></person-group> (<year>2022</year>) <article-title>Investigation of lipid polymer hybrid nanocarriers for oral felodipine delivery: Formulation, method, in-vitro and ex-vivo evaluation.</article-title><source>Iraqi Journal of Pharmaceutical Sciences</source><volume>31</volume>: <fpage>119</fpage>–<lpage>129</lpage>. <ext-link xlink:href="10.31351/vol31iss1pp119-129" ext-link-type="doi" xlink:type="simple">https://doi.org/10.31351/vol31iss1pp119-129</ext-link></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>El-Nabarawi</surname><given-names>MA</given-names></name><name name-style="western"><surname>Shamma</surname><given-names>RN</given-names></name><name name-style="western"><surname>Farouk</surname><given-names>F</given-names></name><name name-style="western"><surname>Nasralla</surname><given-names>SM</given-names></name></person-group> (<year>2020</year>) <article-title>Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and in vivo skin deposition assay.</article-title><source>Journal of Liposome Research</source><volume>30</volume>: <fpage>1</fpage>–<lpage>11</lpage>. <ext-link xlink:href="10.1080/08982104.2019.1577256" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1080/08982104.2019.1577256</ext-link></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Fu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Ma</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G</given-names></name><name name-style="western"><surname>Guo</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Hou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fang</surname><given-names>M</given-names></name></person-group> (<year>2017</year>) <article-title>Improvement of oral bioavailability for nisoldipine using nanocrystals.</article-title><source>Powder Technology</source><volume>305</volume>: <fpage>757</fpage>–<lpage>763</lpage>. <ext-link xlink:href="10.1016/j.powtec.2016.10.068" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.powtec.2016.10.068</ext-link></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Gasmi</surname><given-names>M</given-names></name><name name-style="western"><surname>Rahma</surname><given-names>Z</given-names></name><name name-style="western"><surname>Williams-Hooker</surname><given-names>RW</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>A</given-names></name></person-group> (<year>2023</year>) <article-title>Research Article Production and Characterization of Recombinant Multi-Epitope G Glycoprotein of Rabies Virus.</article-title><source>Medical and Pharmaceutical Journal</source><volume>2</volume>: <fpage>134</fpage>–<lpage>148</lpage>.</mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Ismail</surname><given-names>A</given-names></name><name name-style="western"><surname>Teiama</surname><given-names>M</given-names></name><name name-style="western"><surname>Magdy</surname><given-names>B</given-names></name><name name-style="western"><surname>Sakran</surname><given-names>W</given-names></name></person-group> (<year>2022</year>) Development of a novel bilosomal system for improved oral bioavailability of sertraline hydrochloride: Formulation design, in vitro characterization, and ex vivo and in vivo studies. AAPS PharmSciTech 23: 188. <ext-link xlink:href="10.1208/s12249-022-02339-0" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1208/s12249-022-02339-0</ext-link></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Jassim</surname><given-names>ZE</given-names></name><name name-style="western"><surname>Al-Kinani</surname><given-names>KK</given-names></name><name name-style="western"><surname>Alwan</surname><given-names>ZS</given-names></name></person-group> (<year>2021</year>) <article-title>Preparation and Evaluation of Pharmaceutical Cocrystals for Solubility Enhancement of Dextromethorphan HBr.</article-title><source>International Journal of Drug Delivery Technology</source><volume>11</volume>(<issue>4</issue>): <fpage>1342</fpage>–<lpage>1349</lpage>.</mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Kadhim</surname><given-names>ZJ</given-names></name><name name-style="western"><surname>Rajab</surname><given-names>NA</given-names></name></person-group> (<year>2022</year>) <article-title>Formulation and Characterization of Glibenclamide Nanoparticles as an Oral Film.</article-title><source>International Journal of Drug Delivery Technology</source><volume>12</volume>(<issue>1</issue>): <fpage>387</fpage>–<lpage>394</lpage>.</mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Khafagy</surname><given-names>ES</given-names></name><name name-style="western"><surname>Almutairy</surname><given-names>BK</given-names></name><name name-style="western"><surname>Abu Lila</surname><given-names>AS</given-names></name></person-group> (<year>2023</year>) <article-title>Tailoring of novel bile salt stabilized vesicles for enhanced transdermal delivery of simvastatin: A new therapeutic approach against inflammation.</article-title><source>Polymers</source><volume>15</volume>(<issue>3</issue>): <fpage>677</fpage>. <ext-link xlink:href="10.3390/polym15030677" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/polym15030677</ext-link></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Kharouba</surname><given-names>M</given-names></name><name name-style="western"><surname>El-Kamel</surname><given-names>A</given-names></name><name name-style="western"><surname>Mehanna</surname><given-names>R</given-names></name><name name-style="western"><surname>Thabet</surname><given-names>E</given-names></name><name name-style="western"><surname>Heikal</surname><given-names>L</given-names></name></person-group> (<year>2022</year>) <article-title>Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach.</article-title><source>Drug Delivery</source><volume>29</volume>: <fpage>2925</fpage>–<lpage>2944</lpage>. <ext-link xlink:href="10.1080/10717544.2022.2120925" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1080/10717544.2022.2120925</ext-link></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Kumar</surname><given-names>KV</given-names></name><name name-style="western"><surname>Vidyadhara</surname><given-names>S</given-names></name><name name-style="western"><surname>Babu</surname><given-names>JR</given-names></name></person-group> (<year>2023</year>) <article-title>Favipiravir: Emergent antiviral drug during Covid-19.</article-title><source>Medical and Pharmaceutical Journal</source><volume>2</volume>: <fpage>175</fpage>–<lpage>180</lpage>. <ext-link xlink:href="10.55940/medphar202344" ext-link-type="doi" xlink:type="simple">https://doi.org/10.55940/medphar202344</ext-link></mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Mahmoud</surname><given-names>TM</given-names></name><name name-style="western"><surname>Nafady</surname><given-names>MM</given-names></name><name name-style="western"><surname>Farouk</surname><given-names>HO</given-names></name><name name-style="western"><surname>Mahmoud</surname><given-names>DM</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>YM</given-names></name><name name-style="western"><surname>Zaki</surname><given-names>RM</given-names></name><name name-style="western"><surname>Hamad</surname><given-names>DS</given-names></name></person-group> (<year>2022</year>) Novel bile salt stabilized vesicles-mediated effective topical delivery of diclofenac sodium: A new therapeutic approach for pain and inflammation. Pharmaceuticals (Basel, Switzerland) 15: 1106. <ext-link xlink:href="10.3390/ph15091106" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/ph15091106</ext-link></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Mohsen</surname><given-names>AM</given-names></name><name name-style="western"><surname>Salama</surname><given-names>A</given-names></name><name name-style="western"><surname>Kassem</surname><given-names>AA</given-names></name></person-group> (<year>2020</year>) Development of acetazolamide loaded bilosomes for improved ocular delivery: Preparation, characterization and in vivo evaluation. Journal of Drug Delivery Science and Technology 59: 101910. <ext-link xlink:href="10.1016/j.jddst.2020.101910" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.jddst.2020.101910</ext-link></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Nekkanti</surname><given-names>V</given-names></name><name name-style="western"><surname>Rueda</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Betageri</surname><given-names>GV</given-names></name></person-group> (<year>2016</year>) <article-title>Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine.</article-title><source>International Journal of Pharmaceutics</source><volume>505</volume>: <fpage>79</fpage>–<lpage>88</lpage>. <ext-link xlink:href="10.1016/j.ijpharm.2016.03.065" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.ijpharm.2016.03.065</ext-link></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Noor</surname><given-names>AH</given-names></name><name name-style="western"><surname>Ghareeb</surname><given-names>MM</given-names></name></person-group> (<year>2021</year>) <article-title>Transdermal dissolvable microneedle-mediated delivery of controlled release ondansetron hydrogen chloride nanoparticles.</article-title><source>International Journal of Drug Delivery Technology</source><volume>11</volume>(<issue>3</issue>): <fpage>858</fpage>–<lpage>863</lpage>.</mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Palekar-Shanbhag</surname><given-names>P</given-names></name><name name-style="western"><surname>Lande</surname><given-names>S</given-names></name><name name-style="western"><surname>Chandra</surname><given-names>R</given-names></name><name name-style="western"><surname>Rane</surname><given-names>D</given-names></name></person-group> (<year>2020</year>) <article-title>Bilosomes: Superior vesicular carriers.</article-title><source>Current Drug Therapy</source><volume>15</volume>: <fpage>312</fpage>–<lpage>320</lpage>. <ext-link xlink:href="10.2174/1574885514666190917145510" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2174/1574885514666190917145510</ext-link></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Rajab</surname><given-names>NA</given-names></name></person-group> (<year>2022</year>) <article-title>Formulation and characterization of niosomes for controlled delivery of tolmetin.</article-title><source>Journal of Pharmaceutical Negative Results</source><volume>13</volume>: <fpage>159</fpage>–<lpage>169</lpage>. <ext-link xlink:href="10.47750/pnr.2022.13.04.021" ext-link-type="doi" xlink:type="simple">https://doi.org/10.47750/pnr.2022.13.04.021</ext-link></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Rana</surname><given-names>S</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>N</given-names></name><name name-style="western"><surname>Dutt</surname><given-names>S</given-names></name><name name-style="western"><surname>Patil</surname><given-names>RD</given-names></name></person-group> (<year>2023</year>) <article-title>Hepatoprotective effects of <italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Carissa</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">spinarum</tp:taxon-name-part></tp:taxon-name></italic> extract on carbon tetra chloride induced liver damage in zebrafish (<italic><tp:taxon-name><tp:taxon-name-part taxon-name-part-type="genus">Danio</tp:taxon-name-part> <tp:taxon-name-part taxon-name-part-type="species">rerio</tp:taxon-name-part></tp:taxon-name></italic>).</article-title><source>Medical and Pharmaceutical Journal</source><volume>2</volume>: <fpage>206</fpage>–<lpage>220</lpage>. <ext-link xlink:href="10.55940/medphar202362" ext-link-type="doi" xlink:type="simple">https://doi.org/10.55940/medphar202362</ext-link></mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Saifi</surname><given-names>Z</given-names></name><name name-style="western"><surname>Rizwanullah</surname><given-names>M</given-names></name><name name-style="western"><surname>Mir</surname><given-names>SR</given-names></name><name name-style="western"><surname>Amin</surname><given-names>S</given-names></name></person-group> (<year>2020</year>) Bilosomes nanocarriers for improved oral bioavailability of acyclovir: A complete characterization through in vitro, ex-vivo and in vivo assessment. Journal of Drug Delivery Science and Technology 57: 101634. <ext-link xlink:href="10.1016/j.jddst.2020.101634" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.jddst.2020.101634</ext-link></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Salem</surname><given-names>HF</given-names></name><name name-style="western"><surname>Nafady</surname><given-names>MM</given-names></name><name name-style="western"><surname>Ali</surname><given-names>AA</given-names></name><name name-style="western"><surname>Khalil</surname><given-names>NM</given-names></name><name name-style="western"><surname>Elsisi</surname><given-names>AA</given-names></name></person-group> (<year>2022</year>) <article-title>Evaluation of metformin hydrochloride tailoring bilosomes as an effective transdermal nanocarrier.</article-title><source>International Journal of Nanomedicine</source><volume>17</volume>: <fpage>1185</fpage>–<lpage>1201</lpage>. <ext-link xlink:href="10.2147/IJN.S345505" ext-link-type="doi" xlink:type="simple">https://doi.org/10.2147/IJN.S345505</ext-link></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Salim Mahmood</surname><given-names>A</given-names></name><name name-style="western"><surname>Ammoo</surname><given-names>AM</given-names></name><name name-style="western"><surname>Ali</surname><given-names>MHM</given-names></name><name name-style="western"><surname>Hameed</surname><given-names>TM</given-names></name><name name-style="western"><surname>Al-Hussaniy</surname><given-names>HA</given-names></name><name name-style="western"><surname>Aljumaili</surname><given-names>AAA</given-names></name><name name-style="western"><surname>Al-Fallooji</surname><given-names>MHA</given-names></name><name name-style="western"><surname>Kadhim</surname><given-names>AH</given-names></name></person-group> (<year>2022</year>) Antiepileptic effect of neuroaid on strychnine-induced convulsions in mice. Pharmaceuticals (Basel, Switzerland) 15: 1468. <ext-link xlink:href="10.3390/ph15121468" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/ph15121468</ext-link></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Shaaban</surname><given-names>SM</given-names></name><name name-style="western"><surname>Gaber</surname><given-names>Z</given-names></name><name name-style="western"><surname>Semary</surname><given-names>S</given-names></name><name name-style="western"><surname>Dewidar</surname><given-names>AM</given-names></name></person-group> (<year>2023</year>) <article-title>Impact of vitamin B12 on outcome of early stage luminal A and B breast cancer, single center experience.</article-title><source>Medical and Pharmaceutical Journal</source><volume>2</volume>: <fpage>17</fpage>–<lpage>27</lpage>.</mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Waglewska</surname><given-names>E</given-names></name><name name-style="western"><surname>Pucek-Kaczmarek</surname><given-names>A</given-names></name><name name-style="western"><surname>Bazylińska</surname><given-names>U</given-names></name></person-group> (<year>2020</year>) Novel surface-modified bilosomes as functional and biocompatible nanocarriers of hybrid compounds. Nanomaterials (Basel, Switzerland) 10: 2472. <ext-link xlink:href="10.3390/nano10122472" ext-link-type="doi" xlink:type="simple">https://doi.org/10.3390/nano10122472</ext-link></mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Zafar</surname><given-names>A</given-names></name><name name-style="western"><surname>Alruwaili</surname><given-names>NK</given-names></name><name name-style="western"><surname>Imam</surname><given-names>SS</given-names></name><name name-style="western"><surname>Hadal Alotaibi</surname><given-names>N</given-names></name><name name-style="western"><surname>Alharbi</surname><given-names>KS</given-names></name><name name-style="western"><surname>Afzal</surname><given-names>M</given-names></name><name name-style="western"><surname>Ali</surname><given-names>R</given-names></name><name name-style="western"><surname>Alshehri</surname><given-names>S</given-names></name><name name-style="western"><surname>Alzarea</surname><given-names>SI</given-names></name><name name-style="western"><surname>Elmowafy</surname><given-names>M</given-names></name><name name-style="western"><surname>Alhakamy</surname><given-names>NA</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>MF</given-names></name></person-group> (<year>2021</year>) <article-title>Bioactive Apigenin loaded oral nano bilosomes: Formulation optimization to preclinical assessment.</article-title><source>Saudi pharmaceutical journal: SPJ: the official publication of the Saudi Pharmaceutical Society</source><volume>29</volume>: <fpage>269</fpage>–<lpage>279</lpage>. <ext-link xlink:href="10.1016/j.jsps.2021.02.003" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1016/j.jsps.2021.02.003</ext-link></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation xlink:type="simple"><person-group><name name-style="western"><surname>Zakaria</surname><given-names>MY</given-names></name><name name-style="western"><surname>Fayad</surname><given-names>E</given-names></name><name name-style="western"><surname>Althobaiti</surname><given-names>F</given-names></name><name name-style="western"><surname>Zaki</surname><given-names>I</given-names></name></person-group> (<year>2021</year>) <article-title>Abu Almaaty AH. Statistical optimization of bile salt deployed nanovesicles as a potential platform for oral delivery of piperine: Accentuated antiviral and anti-inflammatory activity in MERS-CoV challenged mice.</article-title><source>Drug Delivery</source><volume>28</volume>: <fpage>1150</fpage>–<lpage>1165</lpage>. <ext-link xlink:href="10.1080/10717544.2021.1934190" ext-link-type="doi" xlink:type="simple">https://doi.org/10.1080/10717544.2021.1934190</ext-link></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
